Spotlight
Video

Combination stifles CLL

mdanderson has 392 videos Subscribe Here

Loading........
Description: The targeted therapy ibrutinib and the antibody rituximab knock down chronic lymphocytic leukemia in 90 % of patients in a clinical trial. Jan Burger, M.D., Ph.D., explains.
Shared By : mdanderson
Posted on : 12/16/13
Added : 4 years ago



More From mdanderson

Nothing found.